Meeting
2015 Genitourinary Cancers Symposium
Patients with metastatic chromophobe renal cell carcinoma treated with sunitinib therapy: Analysis of an international database regarding outcome and comparison to clear cell histology (mccRCC).
Authors
Daniel Keizman
Genitourinary Oncology Service, Division of Oncology, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel
Daniel Keizman , David Sarid , Jae-Lyun Lee , Maya Gottfried , Natalie Maimon , Avishay Sella , Hans J. Hammers , Mario A. Eisenberger , Michael Anthony Carducci , Victoria J. Sinibaldi , Victoria Neiman , Eli Rosenbaum , Eli Gez , Avivit Peer , Wilmosh Mermershtain , Keren Rouvinov , Raanan Berger , Ibrahim Yildiz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 429)
DOI
10.1200/jco.2015.33.7_suppl.429
Abstract #
429
Poster Bd #
C21
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Outcomes of first-line (1L) ipilimumab and nivolumab (IPI-NIVO) and subsequent therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
First Author: Chun Loo Gan
Poster
2018 ASCO Annual Meeting
Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant.
First Author: Yasser Ged
Poster
2018 Genitourinary Cancers Symposium
Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF).
First Author: Yasser Ged
Poster
2018 Genitourinary Cancers Symposium
Optimizing axitinib treatment selection following first-line sunitinib in metastatic renal cell carcinoma.
First Author: Sergio Bracarda